Bluejay Diagnostics Files Q1 2025 10-Q
Ticker: BJDX · Form: 10-Q · Filed: May 13, 2025 · CIK: 1704287
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
Bluejay Diagnostics filed its Q1 2025 10-Q on 5/13/25. Check financials.
AI Summary
Bluejay Diagnostics, Inc. filed its 10-Q for the quarterly period ended March 31, 2025. The company, incorporated in Delaware with its principal executive offices in Acton, MA, reported its financial status. The filing was made on May 13, 2025, under SEC file number 001-41031.
Why It Matters
This filing provides investors with an update on Bluejay Diagnostics' financial performance and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing and does not inherently present new risks.
Key Numbers
- 001-41031 — SEC File Number (Identifies the specific filing for Bluejay Diagnostics, Inc.)
Key Players & Entities
- Bluejay Diagnostics, Inc. (company) — Registrant
- March 31, 2025 (date) — Quarterly period end date
- May 13, 2025 (date) — Filing date
- 001-41031 (other) — SEC file number
- Delaware (other) — State of incorporation
- Acton, MA (location) — Principal executive offices
FAQ
What is the reporting period for this 10-Q filing?
The quarterly period ended March 31, 2025.
When was this 10-Q filed with the SEC?
The filing date was May 13, 2025.
What is the company's SEC file number?
The SEC file number is 001-41031.
In which state was Bluejay Diagnostics, Inc. incorporated?
Bluejay Diagnostics, Inc. was incorporated in Delaware.
What is the principal executive office address for Bluejay Diagnostics, Inc.?
The principal executive offices are located at 360 Massachusetts Avenue, Suite 203, Acton, MA 01720.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Bluejay Diagnostics, Inc. (BJDX).